AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30

Authors: Melchior, SW Noteboom, J Gillitzer, R Lange, PH Blumenstein, BA Vessella, RL
Citation: Sw. Melchior et al., The percentage of free prostate-specific antigen does not predict extracapsular disease in patients with clinically localized prostate cancer before radical prostatectomy, BJU INT, 88(3), 2001, pp. 221-225

Authors: Lange, PH
Citation: Ph. Lange, The Northern Dimension - European energy sources and security, INT POLITIK, 56(1), 2001, pp. 29-36

Authors: Brown, JM Vessella, RL Kostenuik, PJ Dunstan, CR Lange, PH Corey, E
Citation: Jm. Brown et al., Serum osteoprotegerin levels are increased in patients with advanced prostate cancer, CLIN CANC R, 7(10), 2001, pp. 2977-2983

Authors: Lange, PH
Citation: Ph. Lange, Laparoscopic retroperitoneal lymph node dissection - Comment, J ENDOUROL, 15(4), 2001, pp. 453-455

Authors: McNeel, DG Nguyen, LD Ellis, WJ Higano, CS Lange, PH Disis, ML
Citation: Dg. Mcneel et al., Naturally occurring prostate cancer antigen-specific T cell responses of aTh1 phenotype can be detected in patients with prostate cancer, PROSTATE, 47(3), 2001, pp. 222-229

Authors: Lange, PH
Citation: Ph. Lange, High-grade carcinoma of the prostate: A comparison of current local therapies - Editorial comment, UROLOGY, 57(6), 2001, pp. 1126-1127

Authors: Lange, PH
Citation: Ph. Lange, ProstaScint scan for staging prostate cancer, UROLOGY, 57(3), 2001, pp. 402-406

Authors: Thomas, R True, LD Lange, PH Vessella, RL
Citation: R. Thomas et al., Placental bone morphogenetic protein (PLAB) gene expression in normal, pre-malignant and malignant human prostate: Relation to tumor development and progression, INT J CANC, 93(1), 2001, pp. 47-52

Authors: Vessella, RL Wilbur, DS Buhler, K Lange, PH
Citation: Rl. Vessella et al., Experimental models and methods in antibody targeting of renal cell carcinoma, METH MOL M, 53, 2001, pp. 217-242

Authors: Lange, PH
Citation: Ph. Lange, Philosophical reflections on PSA screening - What should we now think and do?, CURR CLIN U, 2001, pp. 97-104

Authors: Thomas, R True, LD Bassuk, JA Lange, PH Vessella, RL
Citation: R. Thomas et al., Differential expression of osteonectin/SPARC during human prostate cancer progression, CLIN CANC R, 6(3), 2000, pp. 1140-1149

Authors: Baker, LH Bahnson, RR Hanks, GE Huben, RP Kantoff, P Kozlowski, JM Kuettel, M Lange, PH Logothetis, C Pow-Sang, JM Roach, M Sandler, H Scardino, PT Taylor, RJ Urban, DA Walsh, PC Wilson, TG
Citation: Lh. Baker et al., NCCN Practice Guidelines for prostate cancer, ONCOLOGY-NY, 14(11A), 2000, pp. 111-119

Authors: Buhler, KR Santucci, RA Royal, RA Whitney, SC Vessella, RL Lange, PH Ellis, WJ
Citation: Kr. Buhler et al., Intermittent androgen suppression in the LuCaP 23.12 prostate cancer xenograft model, PROSTATE, 43(1), 2000, pp. 63-70

Authors: Catalona, WJ Southwick, PC Slawin, KM Partin, AW Brawer, MK Flanigan, RC Patel, A Richie, JP Walsh, PC Scardino, PT Lange, PH Gasior, GH Loveland, KG Bray, KR
Citation: Wj. Catalona et al., Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging, UROLOGY, 56(2), 2000, pp. 255-260

Authors: Vessella, RL Lange, PH Partin, AW Chan, DW Sokoll, LJ Sasse, EA Crawford, ED
Citation: Rl. Vessella et al., Probability of prostate cancer detection based on results of a multicenterstudy using the AxSYM free PSA and total PSA assays, UROLOGY, 55(6), 2000, pp. 909-914

Authors: Catalona, WJ Partin, AW Slawin, KM Naughton, CK Brawer, MK Flanigan, RC Richie, JP Patel, A Walsh, PC Scardino, PT Lange, PH deKernion, JB Southwick, PC Loveland, KG Parson, RE Gasior, GH
Citation: Wj. Catalona et al., Percentage of free PSA in black versus white men for detection and stagingof prostate cancer: A prospective multicenter clinical trial, UROLOGY, 55(3), 2000, pp. 372-376

Authors: McNeel, DG Nguyen, LD Storer, BE Vessella, R Lange, PH Disis, ML
Citation: Dg. Mcneel et al., Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer, J UROL, 164(5), 2000, pp. 1825-1829

Authors: Krieger, JN Riley, DE Vesella, RL Miner, DC Ross, SO Lange, PH
Citation: Jn. Krieger et al., Bacterial DNA sequences in prostate tissue from patients with prostate cancer and chronic prostatitis, J UROL, 164(4), 2000, pp. 1221-1227

Authors: Lin, DW Santucci, RA Mayo, ME Lange, PH Mitchell, ME
Citation: Dw. Lin et al., Urodynamic evaluation and long-term results of the orthotopic gastric neobladder in men, J UROL, 164(2), 2000, pp. 356-359

Authors: Lange, PH
Citation: Ph. Lange, Society of Urologic Oncology - Introduction, J UROL, 163(6), 2000, pp. 1784-1784

Authors: Melchior, SW Brown, LG Figg, WD Quinn, JE Santucci, RA Brunner, J Thuroff, JW Lange, PH Vessella, RL
Citation: Sw. Melchior et al., Effects of phenylbutyrate on proliferation and apoptosis in human prostatecancer cells in vitro and in vivo, INT J ONCOL, 14(3), 1999, pp. 501-508

Authors: Liu, AY True, LD LaTray, L Ellis, WJ Vessella, RL Lange, PH Higano, CS Hood, L van den Engh, G
Citation: Ay. Liu et al., Analysis and sorting of prostate cancer cell types by flow cytometry, PROSTATE, 40(3), 1999, pp. 192-199

Authors: Crawford, ED Rosenblum, M Ziada, AM Lange, PH
Citation: Ed. Crawford et al., Overview: Hormone refractory prostate cancer, UROLOGY, 54(6A), 1999, pp. 1-7

Authors: Santucci, RA Park, CH Mayo, ME Lange, PH
Citation: Ra. Santucci et al., Continence and urodynamic parameters of continent urinary reservoirs: Comparison of gastric, ileal, ileocolic, right colon, and sigmoid segments, UROLOGY, 54(2), 1999, pp. 252-257

Authors: Southwick, PC Catalona, WJ Partin, AW Slawin, KM Brawer, MK Flanigan, RC Patel, A Richie, JP Walsh, PC Scardino, PT Lange, PH Gasior, GH Parson, RE Loveland, KG
Citation: Pc. Southwick et al., Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: A prospective multicenter clinical trial, J UROL, 162(4), 1999, pp. 1346-1351
Risultati: 1-25 | 26-30